#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Genotypic Heterogeneity of Hepatitis C virus (HCV) from Blood Donors in the Czech Republic


Authors: V. Němeček 1;  O. Strunecký 1
Authors place of work: Národní referenční laboratoř pro virové hepatitidy, Státní zdravotní ústav, Praha 1
Published in the journal: Epidemiol. Mikrobiol. Imunol. 58, 2009, č. 2, s. 63-72

Summary

Study objectives.
Analysis of the genotypic distribution of HCV from blood donors screened in the Czech Republic in 1999-2007 and sequence heterogeneity of HCV isolates in the NS5 region of the HCV genome.

Material and methods.
A total of 402 archived serum samples from blood donors collected in 1999-2007 and confirmed positive for anti-HCV antibodies were tested for HCV RNA. In 220 HCV RNA positive sera, PCR was used to amplify a 401-nt fragment of the NS5 region of the HCV genome. The PCR product was sequenced and phylogenetic analysis of the obtained nucleotide sequences was carried out. Genotyping was performed based on the comparison with the sequence data available in the Genbank database. Regression analysis and non-parametric Pearson’s chi-square test were used for statistical analysis of the distribution of genotypes by age, sex , sampling place and sampling year.

Results.
In a representative set of 188 blood donors from the Czech Republic, the following HCV genotypes were determined: 1b (66%), 1a (13.3%), 3 (19.7%), 2a (0.5%) and 2b (0.5%). In 1999-2007, genotype 1b showed a significantly decreasing trend while genotype 3a was becoming significantly more frequent and the incidence of genotype 1a remained unchanged. It was found that the proportion of genotype 1b rises with increasing age of blood donors in contrast to genotypes 1a a 3a. Genotype 1b was detected significantly more frequently in females and genotype 3a significantly predominated in males. Any significant difference was not found in the geographical distribution of HCV genotypes. The mean HCV viral load was 9.6 x 105 I.U./ml.

Conclusions.
The predominant HCV genotype among blood donors in the Czech Republic is 1b, showing a significant downward trend in 1999-2007. The increasing prevalence of genotype 3a can be associated with changes in the route of HCV transmission, more precisely with the considerably increased incidence of HCV in injecting drug users over the last 15 years. Surprisingly, the incidence of genotype 1a remained unchanged over the study period.

Key words:
HCV – genotype – blood donors.


Zdroje

1. Brojer, E., Gronowska, A., Medynska, J., Grabarczyk, P., Mikulska, M. et al. The hepatitis C virus genotype and subtype frequency in hepatitis C virus RNA-positive, hepatitis C virus antibody-negative blood donors identified in the nucleic acid test screening program in Poland. Transfusion, 2004,44, 1706-1710.

2. Cantaloube, J. F., Gallian, P., Attoui, H., Biagini, P.et al. Genotype distribution and molecular epidemiology of hepatitis C virus in blood donors from southeast France. J Clin Microbiol, 2005,43, 3624-3629.

3. Chlabicz, S., Flisiak, R., Kowalczuk, O., Wiercinska-Drapalo, A., Pytel-Krolczuk, B.et al. High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in north-eastern Poland. J Med Virol, 2008,80, 615-618.

4. Choi, J., Xu, Z., Ou, J. H. Triple decoding of hepatitis C virus RNA by programmed translational frameshifting. Mol Cell Biol, 2003,23, 1489-1497.

5. Esteban, J. I., Sauleda, S., Quer, J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol, 2008,48, s.148-162.

6. Frank, C., Mohamed, M. K., Strickland, G. T., Lavanchy, D., Arthur, R. R et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet, 2000,355, 887-891.

7. Gervain, J., Simon, G., Jr., Papp, I., Szabone, B. K. [Determination of the type and subtype of the hepatitis C virus in chronic viral hepatitis patients in Hungary]. Orv Hetil, 2001,142, 1315-1319.

8. Krekulova, L., Rehak, V., Madrigal, N., Johnson, M., Killoran, P., Riley, L. W. Genotypic and epidemiologic characteristics of hepatitis C virus infections among recent injection drug user and nonuser populations. Clin Infect Dis, 2001,33, 1435-1438.

9. Martinot-Peignoux, M., Roudot-Thoraval, F., Mendel, I., Coste, J., Izopet, J.et al. Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP. J Viral Hepat, 1999,6, 435-443.

10. Nemecek, V., Castkova, J., Fritz, P., Linhartova, A., Svandova, E.et al. The 2001 serological survey in the Czech Republic—viral hepatitis. Cent Eur J Public Health, 2003,11 Suppl, S54-S61.

11. Payan, C., Roudot-Thoraval, F., Marcellin, P., Bled, N., Duverlie, G. et al. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. J Viral Hepat, 2005,12, 405-413.

12. Rantala, M., van de Laar, M. J. Surveillance and epidemiology of hepatitis B and C in Europe - a review. Euro Surveill, 2008,13.

13. Shev, S., Widell, A., Foberg, U., Fryden, A., Hermodsson, S., et al. HCV genotypes in Swedish blood donors as correlated to epidemiology, liver disease and hepatitis C virus antibody profile. Infection, 1995,23, 253-257.

14. Simmonds, P. Genetic diversity and evolution of hepatitis C virus-15 years on. J Gen Virol, 2004,85, 3173-3188.

15. Simmonds, P., Alberti, A., Alter, H. J., Bonino, F., Bradley, D. W., et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology, 1994,19, 1321-1324.

16. Tallo, T., Norder, H., Tefanova, V., Krispin, T., Schmidt, J.et al. Genetic characterization of hepatitis C virus strains in Estonia: fluctuations in the predominating subtype with time. J Med Virol, 2007,79, 374-382.

17. Urbánek P., Subhanová I., Janoušová, E., Dušek L., Mareček Z. et al. Účinnost terapie pegylovaným interferonem a ribavirinem u pacientů s chronickou HCV infekcí. Vnitř lék, 2009 (v tisku).

18. Viazov, S., Kuzin, S., Paladi, N., Tchernovetsky, M., Isaeva, E., et al. Hepatitis C virus genotypes in different regions of the former Soviet Union (Russia, Belarus, Moldova, and Uzbekistan). J Med Virol, 1997,53, 36-40.

Štítky
Hygiene and epidemiology Medical virology Clinical microbiology
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#